Topical Drug Delivery Considerations for Biologics
According to the analyst firm Global Information, the demand for biologics and biosimilars is estimated to grow to more than $100 billion in 2015, continuing the double-digit growth rate seen in the last decade. As the industry continues to grow, alternative delivery methods are of increasing interest—particularly the topical delivery of large molecules.
University of North Carolina (School of Medicine)
Researchers at the University of North Carolina School of Medicine needed testing, scale-up and manufacturing of intra-nasally administered Oxytocin for a clinical study involving children with Autism. The research, funded by NICHD (National Institute of Child Health and Human Development), originally involved a commercial pharmaceutical company.